Abbott Neuromodulation's Jenn Wong discusses the TRANSCEND trial for depression, imaging tech advancing DBS and other ...
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...
A new technique involving ultra-powerful MRI scanners could help doctors identify tiny differences in the brains of people ...
A new technique has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients ...
A new technique involving ultra-powerful MRI scanners could help doctors identify tiny differences in the brains of people ...
A new technique has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients ...
A new imaging technique is helping ultra-powerful MRI scanners detect tiny differences in the brains of patients with ...
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
A new technique has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients ...
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback